UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 109

Sortiert nach

Association between 25-hydroxyvitamin D, somatic muscle weakness and falls risk in end-stage renal failure

Clinical endocrinology (Oxford), 2010-09, Vol.73 (3), p.299-304

2010

Volltextzugriff (PDF)

Efficacy, side effects and route of administration are more important than frequency of dosing of anti-osteoporosis treatments in determining patient adherence: a critical review of published articles from 1970 to 2009

Osteoporosis international, 2011-03, Vol.22 (3), p.741-753

2011

Volltextzugriff (PDF)

Diagnosis of primary hyperparathyroidism: controversies, practical issues and the need for Australian guidelines

Internal medicine journal, 2003-12, Vol.33 (12), p.598-603

Glendenning, P.

2003

Volltextzugriff (PDF)

What is the therapeutic target level of 25-hydroxyvitamin D in osteoporosis and how accurately can we measure it?

Internal medicine journal, 2012-10, Vol.42 (10), p.1069-1072

2012

Volltextzugriff (PDF)

Prolonged vitamin D intoxication: presentation, pathogenesis and progress

Internal medicine journal, 2013-10, Vol.43 (10), p.1148-1150

2013

Volltextzugriff (PDF)

Association between 25-OH vitamin D and insulin is independent of lipoatrophy in HIV

Clinical endocrinology (Oxford), 2012-02, Vol.76 (2), p.201-206

2012

Volltextzugriff (PDF)

Current assays overestimate 25-hydroxyvitamin D3 and underestimate 25-hydroxyvitamin D2 compared with HPLC: need for assay-specific decision limits and metabolite-specific assays

Annals of clinical biochemistry, 2006-01, Vol.43 (Pt 1), p.23

2006

Volltextzugriff (PDF)

Efficacy, side-effects and route of administration are more important than frequency of dosing of anti-osteoporosis treatments in determining patient preference and compliance: A critical review of published articles from 1970-2009

Bone (New York, N.Y.), 2010-06, Vol.47, p.S206-S206

2010

Volltextzugriff (PDF)

ORIGINAL ARTICLE: Association between 25-hydroxyvitamin D, somatic muscle weakness and falls risk in end-stage renal failure

Clinical endocrinology (Oxford), 2010-09, Vol.73 (3), p.299-304

2010

Volltextzugriff (PDF)

Inappropriate thyroid-stimulating hormone secretion

Internal medicine journal, 2002-03, Vol.32 (3), p.120-121

Glendenning, P

2002

Volltextzugriff (PDF)

High prevalence of osteoporosis in cardiac transplant recipients and discordance between biochemical turnover markers and bone histomorphometry

Clinical endocrinology (Oxford), 1999-03, Vol.50 (3), p.347-355

1999

Volltextzugriff (PDF)

Serum 25-hydroxyvitamin D levels in vitamin D-insufficient hip fracture patients after supplementation with ergocalciferol and cholecalciferol

Bone (New York, N.Y.), 2009-11, Vol.45 (5), p.870-875

2009

Volltextzugriff (PDF)

Issues of standardization and assay-specific clinical decision limits for the measurement of 25-hydroxyvitamin D

The American journal of clinical nutrition, 2003-02, Vol.77 (2), p.522-523

Glendenning, Paul

2003

Volltextzugriff (PDF)

Efficacy and safety of pharmacological agents in managing osteoporosis in the old old: Review of the evidence

Bone (New York, N.Y.), 2009-05, Vol.44 (5), p.744-751

2009

Volltextzugriff (PDF)

Long-term efficacy, safety, and patient acceptability of ibandronate in the treatment of postmenopausal osteoporosis

International journal of women's health, 2015-01, Vol.7 (default), p.7-17

2015

Volltextzugriff (PDF)

Developments in multicavity hot runner tooling

Medical device technology, 2009-05, Vol.20 (3), p.36

Glendenning, P

2009

Volltextzugriff (PDF)

Reply

Internal medicine journal, 2004-11, Vol.34 (11), p.656-656

Glendenning, P.

2004

Volltextzugriff (PDF)

Reply

Internal medicine journal, 2004-11, Vol.34 (11), p.656-656

Glendenning, P.

2004

Volltextzugriff (PDF)

Reply

Internal medicine journal, 2004-11, Vol.34 (11), p.656-656

Glendenning, P.

2004

Volltextzugriff (PDF)

Hypothalamic gangliocytoma associated with a prolactinoma: a case report and review of the literature

Pathology, 2012, Vol.44, p.S85-S85

2012

Volltextzugriff (PDF)

Bone markers in patients with multiple myeloma and monoclonal gammopathy of undetermined significance

Internal medicine journal, 2002-01, Vol.32 (1-2), p.56-57

2002

Volltextzugriff (PDF)

Pituitary apoplexy: the importance of citing the differential diagnosis

Medical journal of Australia, 2000-11, Vol.173 (10), p.548-549

2000

Volltextzugriff (PDF)

Endotoxin induced TNF and IL-10 mRNA production is higher in male than female donors: Correlation with elevated expression of TLR4

Cellular immunology, 2008-01, Vol.251 (2), p.69-71

2008

Volltextzugriff (PDF)

Investigating hypophosphataemia

BMJ (Online), 2014-05, Vol.348, p.g3172

2014

Volltextzugriff (PDF)

Geochemistry of the metavolcanic rocks in the vicinity of the MacLellan Au–Ag deposit and an evaluation of the tectonic setting of the Lynn Lake greenstone belt, Canada: Evidence for a Paleoproterozoic-aged rifted continental margin

Lithos, 2015-09, Vol.233, p.46-68

2015

Volltextzugriff (PDF)

1 – 25 von 109

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(100)
Mit Volltextzugriff
(97)

Publikationsform

Sprache

Englisch
(109)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Association between 25-hydroxyvitamin D, somatic muscle weakness and falls risk in end-stage renal failure

Efficacy, side effects and route of administration are more important than frequency of dosing of anti-osteoporosis treatments in determining patient adherence: a critical review of published articles from 1970 to 2009

Diagnosis of primary hyperparathyroidism: controversies, practical issues and the need for Australian guidelines

What is the therapeutic target level of 25-hydroxyvitamin D in osteoporosis and how accurately can we measure it?

Prolonged vitamin D intoxication: presentation, pathogenesis and progress

Association between 25-OH vitamin D and insulin is independent of lipoatrophy in HIV

Current assays overestimate 25-hydroxyvitamin D3 and underestimate 25-hydroxyvitamin D2 compared with HPLC: need for assay-specific decision limits and metabolite-specific assays

Efficacy, side-effects and route of administration are more important than frequency of dosing of anti-osteoporosis treatments in determining patient preference and compliance: A critical review of published articles from 1970-2009

ORIGINAL ARTICLE: Association between 25-hydroxyvitamin D, somatic muscle weakness and falls risk in end-stage renal failure

Inappropriate thyroid-stimulating hormone secretion

High prevalence of osteoporosis in cardiac transplant recipients and discordance between biochemical turnover markers and bone histomorphometry

Serum 25-hydroxyvitamin D levels in vitamin D-insufficient hip fracture patients after supplementation with ergocalciferol and cholecalciferol

Issues of standardization and assay-specific clinical decision limits for the measurement of 25-hydroxyvitamin D

Efficacy and safety of pharmacological agents in managing osteoporosis in the old old: Review of the evidence

Long-term efficacy, safety, and patient acceptability of ibandronate in the treatment of postmenopausal osteoporosis

Developments in multicavity hot runner tooling

Reply

Reply

Reply

Hypothalamic gangliocytoma associated with a prolactinoma: a case report and review of the literature

Bone markers in patients with multiple myeloma and monoclonal gammopathy of undetermined significance

Pituitary apoplexy: the importance of citing the differential diagnosis

Endotoxin induced TNF and IL-10 mRNA production is higher in male than female donors: Correlation with elevated expression of TLR4

Investigating hypophosphataemia

Geochemistry of the metavolcanic rocks in the vicinity of the MacLellan Au–Ag deposit and an evaluation of the tectonic setting of the Lynn Lake greenstone belt, Canada: Evidence for a Paleoproterozoic-aged rifted continental margin

Suchergebnisse filtern